Quarles & Brady 's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
- Penetration Testing In Healthcare: HIPAA And GDPR Requirements
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Implementing eSource: A Guide For Operations And Technology Roles
By recognizing and addressing the challenges associated with eSource integration, research facilities can fully harness its transformative potential, optimizing efficiency and reliability.
-
From Startup To Public Company: Scaling Finance Operations
When basic tools no longer support your growing company, robust systems, such as ERPs, become essential for managing complex financial reporting, regulatory compliance, and multi-entity tracking.
-
One Key To Choosing The Best eClinical Technology Vendor
Explore why the integration of etechnologies is critical in the modernization and optimization of clinical trials, and how the right partner will ensure studies are more efficient, reliable, and inclusive.
-
Addressing The Challenges Of eCOA Licensing
How can you combat the instrument licensing and linguistic validation challenges associated with adopting electronic Clinical Outcome Assessments (eCOA), ensuring quick access to source files?
-
What Does EDC Look Like In 2024 And Beyond?
Read along as industry experts from TrialKit offer insights into the anticipated developments and challenges surrounding electronic data capture.
-
8 Key Applications Of Real-World Data In Multiple Myeloma Therapy Development
Explore how therapeutic area (TA) datasets can be leveraged to address the challenges multiple myeloma (MM) presents in the field of hematologic malignancies.
-
Modern Post-Market Trials Driven By RWD – Is Your EDC Ready?
Explore the transformative role of real-world data (RWD) and advanced Electronic Data Capture (EDC) systems in post-market research, marking a departure from traditional Phase IV trials.
-
Data Distortions: When Statistics Can Lead Us Astray In Drug Safety
Post-marketing signals and AE frequency comparisons need careful interpretation. Discover how confounding factors and misunderstood statistics often mislead drug safety professionals.
-
Building A Competitive Advantage With EDC
Discover how an EDC platform that was flexible and easy to use was able to help a CRO build the most attractive offerings possible for their customers.
-
Vanderbilt's Advice For Sponsors: How To Make Working With Your EDC Easier For Sites
Learn how research sites like Vanderbilt University Medical Center speed study timelines and drive higher quality data entry with a modern EDC.